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Background
The Polymerase II-Associated Factor 1 (PAF1) is a cellular
protein with essential roles in transcription activation and
repression, polyA tail cleavage, regulation of RNA poly-
merase elongation, regulation of gene expression, cell
cycle control and mRNA quality surveillance[1]. It is part
of a multicomponent complex together with other cellular
proteins including SKI8, LEO1, CDC73, RTF1 and CTR9
[1]. We described that PAF1 has antiviral effect against
HIV-1 that manifests early in the replication cycle [2].
Marazzi et al. described that PAF1 also inhibits influenza
virus infection suggesting that PAF1 could have a broad
antiviral activity [3]. Localisation of endogenous PAF1 is
mainly in the nucleus but also in the cytoplasm. We pro-
pose three hypotheses: that PAF1 acts from the cytoplasm
or the nucleus or both.
Materials and methods
To investigate a link between the antiviral function and
cellular localisation of PAF1, human PAF1 mutants
were engineered with altered nuclear localization signals.
Wild type and mutant PAF1 constructs were charac-
terised by confocal imaging, cellular fractionation and
ability to inhibit HIV-1, 2 and SIV. Viral infectivity was
measured by quantitative RT-PCR of early and late
HIV-1 transcripts as well as focus forming units.
Results
Results describing the requirements for specific cellular
localisations of PAF1 for viral inhibition will be
presented.
Conclusion
Understanding the mechanism by which PAF1 modu-
lates HIV-1 infection could unravel novel drug targets
not only against HIV-1 infection but possibly against
other viruses.
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